Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuyuan granule for borderline hypertension
ChiCTR2200062182Phase 2Not yet recruiting
- Sponsor
- Eye Hospital, China Academy of Chinese Medical Sciences
- Start
- Nov 2021
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in prehypertension comparing Placebo + health education with Fuyuan granule + health education (2 arms). Primary endpoint: Office blood pressure. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
Fuyuan granule
03
Conditions
prehypertension
Beyond the preview
Go deeper on ChiCTR2200062182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062182.